Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair
ACE
ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "
2 other identifiers
interventional
306
1 country
1
Brief Summary
Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter. The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 16, 2005
CompletedFirst Posted
Study publicly available on registry
September 23, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedApril 1, 2009
February 1, 2009
5.1 years
September 16, 2005
March 31, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death and major adverse events
4 years
Secondary Outcomes (1)
Minor adverse events (systemic vascular or non vascular complications)
4 years
Study Arms (2)
1
ACTIVE COMPARATORsurgery - open repair
2
EXPERIMENTALendovascular procedure
Interventions
An endovascular stent graft is a tube composed of fabric supported by a metal mesh called a stent. It can be used for a variety of conditions involving the blood vessels, but most commonly to reinforce a weak spot in an artery called an aneurysm. Over time, blood pressure and other factors can cause this weak area to bulge like a balloon and eventually enlarge and rupture. The stent graft seals tightly with your artery above and below the aneurysm. The graft is stronger than the weakened artery and allows blood to pass through it without pushing on the bulge. Physicians typically use endovascular stent grafting to treat abdominal aortic aneurysms (AAAs).
Conventional repair consist in open repair. Different types of surgery can be done : minimal incision aortic surgery (MIAS), transperitoneal approach (TPA), retroperitoneal repair, or conventional median laparotomy.
Eligibility Criteria
You may qualify if:
- Patients aged 50 years old or more (more than 80 possible depending on physiological age)
- Level 0, 1, or 2 of operative risk
- Abdominal aortic aneurysm with a diameter \> or equal to 50 mm or \> or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm;
- Aortic neck superior or equal to 1.5 cm
- No stenosis superior or equal to 75% of the superior mesenteric artery
- Proximal neck angulation inferior to 80°
- Diameter of the iliac arteries compatible with introducer sheath
- Inform consent signed
You may not qualify if:
- Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm
- Thrombus or major calcification in the neck
- Diameter of the iliac arteries not compatible with introducer sheath
- Level 3 of operative risk
- History of major iodine allergy (Quincke oedema, anaphylactic shock)
- Other comorbidity with life expectancy less than 6 months
- Follow up impossible during the trial
- Participation in another trial
- Inform consent not signed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Henri Mondor
Créteil, 94 010, France
Related Publications (2)
Lederle FA. Endovascular repair of abdominal aortic aneurysm--round two. N Engl J Med. 2005 Jun 9;352(23):2443-5. doi: 10.1056/NEJMe058126. No abstract available.
PMID: 15944430BACKGROUNDBecquemin JP, Pillet JC, Lescalie F, Sapoval M, Goueffic Y, Lermusiaux P, Steinmetz E, Marzelle J; ACE trialists. A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients. J Vasc Surg. 2011 May;53(5):1167-1173.e1. doi: 10.1016/j.jvs.2010.10.124. Epub 2011 Jan 26.
PMID: 21276681DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yann JOUSSET, MD
CHU Angers - Hôtel Dieu
- PRINCIPAL INVESTIGATOR
Jean M Pernes, MD
Hôpital privé d'Antony
- PRINCIPAL INVESTIGATOR
Pierre Y Meaulle, MD
Clinique mutualiste des Eaux Claires, Grenoble
- PRINCIPAL INVESTIGATOR
Jean P Favre, MD
CHU Hôpital Nord, Saint-Etienne
- PRINCIPAL INVESTIGATOR
Jacques Watelet, MD
Hôpital Charles Nicolle, Rouen
- PRINCIPAL INVESTIGATOR
Patrick Lermusiaux, MD
CHRU -Hôpital Trousseau, Tours
- PRINCIPAL INVESTIGATOR
Jean F Heautot, MD
CHU de Pontchaillou, Rennes
- PRINCIPAL INVESTIGATOR
Mohamad KOUSSA, MD
Hôpital Cardiologique , Lille
- PRINCIPAL INVESTIGATOR
Patrice BERGERON, MD
Hôpital St Joseph, Marseille
- PRINCIPAL INVESTIGATOR
Philippe CHAILLOU, MD
Hôpital Nord Laennec, Nantes
- PRINCIPAL INVESTIGATOR
Eric CHEYSSON, MD
Centre Hospitalier René Dubos, Pontoise
- PRINCIPAL INVESTIGATOR
Arnaud DEMON, MD
CH de Valenciennes
- PRINCIPAL INVESTIGATOR
Jean C PILLET, MD
Nouvelles Cliniques Nantaises, Nantes
- PRINCIPAL INVESTIGATOR
Eric STEINMETZ, MD
CHU de Dijon - Hôpital du Bocage
- PRINCIPAL INVESTIGATOR
Michel LEVADE, MD
Clinique Pasteur Toulouse
- PRINCIPAL INVESTIGATOR
Jean CARDON, MD
Clinique des Franciscaines, Nimes
- PRINCIPAL INVESTIGATOR
Pierre-Edouard MAGNAN, MD
CHU Timone, Marseille
- PRINCIPAL INVESTIGATOR
Michel Batt, MD
Hôpital St-Roch, Nice
- PRINCIPAL INVESTIGATOR
Pierre GOUNY, MD
Hopital de la cavale blanche, Brest
- PRINCIPAL INVESTIGATOR
Antoine Lucas, MD
CHU Pontchaillou
- STUDY CHAIR
Jean P Becquemin, MD
Hopital Henri Mondor, Créteil
- STUDY CHAIR
Marc Sapoval, MD
HEGP, Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 16, 2005
First Posted
September 23, 2005
Study Start
January 1, 2003
Primary Completion
February 1, 2008
Study Completion
February 1, 2009
Last Updated
April 1, 2009
Record last verified: 2009-02